Categories
Laurus Labs Limited — Updates, 30-04-2026: Press Release
30-04-2026 · 03:26 pm
Laurus Labs reported strong FY26 results: Revenue up 23% to ₹6,813 Cr, EBITDA surged 64% to ₹1,826 Cr (26.8% margin), and Net Profit jumped 148% to ₹889 Cr. Growth was driven by CDMO and Affordable Medicines. Capex will increase for future expansion. Interim dividend ₹1.2/share declared.
No comments yet. Be the first to comment!